Literature DB >> 6420306

Complement components and activation in primary biliary cirrhosis.

S Lindgren, A B Laurell, S Eriksson.   

Abstract

Total complement activity was normal in 18 patients with primary biliary cirrhosis using two hemolytic assays capable of distinguishing between defects in classical and alternative pathways. Activation of the classical pathway was demonstrated in all patients by formation of complexes between C1r, C1s, and C1 inactivator. Large amounts of free C1q, not in complex with C1r and C1s, were demonstrated in the majority of patient sera. Furthermore, C4 levels were within the normal range or slightly subnormal. No evidence for alternative pathway activation was found. Increased mean levels of several complement components, in particular C1 inactivator, C2, C3, factor B, factor H, were noted. A significant correlation between these complement factors, derived mainly from the liver, and ceruloplasmin suggests that this elevation might be secondary to cholestasis. In contrast, no significant correlation with levels of early reacting acute phase reactants, immunoglobulins, or circulating immune complex-like material were observed. It is concluded that activation of the complement system by the classical pathway is common in patients with primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420306     DOI: 10.1002/hep.1840040102

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Complement inhibition alleviates paraquat-induced acute lung injury.

Authors:  Shihui Sun; Hanbin Wang; Guangyu Zhao; Yingbo An; Yan Guo; Lanying Du; Hongbin Song; Fei Qiao; Hong Yu; Xiaohong Wu; Carl Atkinson; Shibo Jiang; Stephen Tomlinson; Yusen Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

Review 2.  Recent developments in primary biliary cirrhosis: etiology and treatment.

Authors:  U Hopf; R Stemerowicz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

5.  Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat.

Authors:  I Myara; G Miech; M Fabre; M Mangeot; A Lemonnier
Journal:  Br J Exp Pathol       Date:  1987-02

6.  Complement profile in primary biliary cirrhosis.

Authors:  M Schlesinger; C Benbassat; Y Shoenfeld
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Zahra Razaghi; Naser Nejadi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020

8.  C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation.

Authors:  Katrin Färber; Giselle Cheung; Daniel Mitchell; Russell Wallis; Eberhard Weihe; Wilhelm Schwaeble; Helmut Kettenmann
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.